ATE511348T1 - Transgenes modell für morbus alzheimer - Google Patents
Transgenes modell für morbus alzheimerInfo
- Publication number
- ATE511348T1 ATE511348T1 AT05722229T AT05722229T ATE511348T1 AT E511348 T1 ATE511348 T1 AT E511348T1 AT 05722229 T AT05722229 T AT 05722229T AT 05722229 T AT05722229 T AT 05722229T AT E511348 T1 ATE511348 T1 AT E511348T1
- Authority
- AT
- Austria
- Prior art keywords
- alzheimer
- disease
- transgene
- transgenic
- transgenic model
- Prior art date
Links
- 208000024827 Alzheimer disease Diseases 0.000 title abstract 5
- 238000012301 transgenic model Methods 0.000 title 1
- 101710137189 Amyloid-beta A4 protein Proteins 0.000 abstract 2
- 102100022704 Amyloid-beta precursor protein Human genes 0.000 abstract 2
- 101710151993 Amyloid-beta precursor protein Proteins 0.000 abstract 2
- 108700019146 Transgenes Proteins 0.000 abstract 2
- DZHSAHHDTRWUTF-SIQRNXPUSA-N amyloid-beta polypeptide 42 Chemical compound C([C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(O)=O)[C@@H](C)CC)C(C)C)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC(O)=O)C(C)C)C(C)C)C1=CC=CC=C1 DZHSAHHDTRWUTF-SIQRNXPUSA-N 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 230000035772 mutation Effects 0.000 abstract 2
- 230000009261 transgenic effect Effects 0.000 abstract 2
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 239000000032 diagnostic agent Substances 0.000 abstract 1
- 229940039227 diagnostic agent Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000003834 intracellular effect Effects 0.000 abstract 1
- 230000008506 pathogenesis Effects 0.000 abstract 1
- 230000001717 pathogenic effect Effects 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 238000012216 screening Methods 0.000 abstract 1
- 229940124597 therapeutic agent Drugs 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
- A01K67/0275—Genetically modified vertebrates, e.g. transgenic
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/10—Mammal
- A01K2227/105—Murine
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
- A01K2267/0306—Animal model for genetic diseases
- A01K2267/0312—Animal model for Alzheimer's disease
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Environmental Sciences (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Animal Behavior & Ethology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Plant Pathology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Toxicology (AREA)
- Physics & Mathematics (AREA)
- Animal Husbandry (AREA)
- Biodiversity & Conservation Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Eye Examination Apparatus (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0400707A SE0400707D0 (sv) | 2004-03-22 | 2004-03-22 | Transgenic animal model |
| PCT/SE2005/000383 WO2005089539A1 (en) | 2004-03-22 | 2005-03-17 | Transgenic model for alzheimer’s disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE511348T1 true ATE511348T1 (de) | 2011-06-15 |
Family
ID=32067463
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT05722229T ATE511348T1 (de) | 2004-03-22 | 2005-03-17 | Transgenes modell für morbus alzheimer |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US7709695B1 (de) |
| EP (1) | EP1729569B1 (de) |
| JP (1) | JP4914343B2 (de) |
| AT (1) | ATE511348T1 (de) |
| AU (1) | AU2005224992B2 (de) |
| CA (1) | CA2560551A1 (de) |
| DK (1) | DK1729569T3 (de) |
| ES (1) | ES2367310T3 (de) |
| SE (1) | SE0400707D0 (de) |
| WO (1) | WO2005089539A1 (de) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2001268005A1 (en) | 2000-07-07 | 2002-01-21 | Lars Lannfelt | Prevention and treatment of alzheimer's disease |
| SE0401601D0 (sv) | 2004-06-21 | 2004-06-21 | Bioarctic Neuroscience Ab | Protofibril specific antibodies and uses thereof |
| PL2004688T5 (pl) | 2006-03-23 | 2014-09-30 | Bioarctic Neuroscience Ab | Ulepszone przeciwciała wobec protofibryli oraz ich zastosowania |
| ES2562224T3 (es) * | 2008-04-14 | 2016-03-03 | Alzinova Ab | Monómeros y oligómeros de beta amiloide estables |
| KR101634244B1 (ko) * | 2014-06-19 | 2016-06-29 | 한경대학교 산학협력단 | Talen을 이용하여 grk5 넉아웃 마우스를 제조하는 방법 |
| SMT202100263T1 (it) | 2014-07-10 | 2021-07-12 | Eisai R&D Man Co Ltd | Anticorpi leganti protofibrille a-beta migliorati |
| WO2016086197A1 (en) | 2014-11-25 | 2016-06-02 | The Brigham And Women's Hospital, Inc. | Method of identifying and treating a person having a predisposition to or afflicted with a cardiometabolic disease |
| WO2016085876A1 (en) | 2014-11-25 | 2016-06-02 | The Broad Institute Inc. | Clonal haematopoiesis |
| AU2021225696B2 (en) * | 2020-02-28 | 2024-11-14 | Rznomics Inc. | Trans-splicing ribozyme specific to APOE4 RNA and use thereof |
| CN113957095A (zh) * | 2021-10-22 | 2022-01-21 | 江苏集萃药康生物科技股份有限公司 | 一种用于构建阿尔兹海默症动物模型的构建方法及其核酸组合物和应用 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK0620849T3 (da) | 1992-01-07 | 2003-10-20 | Elan Pharm Inc | Transgene dyremodeller for Alzheimer's sygdom |
| US5604102A (en) | 1992-04-15 | 1997-02-18 | Athena Neurosciences, Inc. | Methods of screening for β-amyloid peptide production inhibitors |
| US5455169A (en) | 1992-06-04 | 1995-10-03 | Alzheimer's Institute Of America, Inc. | Nucleic acids for diagnosing and modeling Alzheimer's disease |
| US5449604A (en) | 1992-10-21 | 1995-09-12 | University Of Washington | Chromosome 14 and familial Alzheimers disease genetic markers and assays |
| WO1995011968A1 (en) | 1993-10-27 | 1995-05-04 | Athena Neurosciences, Inc. | Transgenic animals harboring app allele having swedish mutation |
| US5877399A (en) | 1994-01-27 | 1999-03-02 | Johns Hopkins University | Transgenic mice expressing APP-Swedish mutation develop progressive neurologic disease |
| JPH07238035A (ja) * | 1994-02-28 | 1995-09-12 | Kyowa Hakko Kogyo Co Ltd | βアミロイド蛋白質分解剤 |
| US5777194A (en) | 1995-04-26 | 1998-07-07 | Cephalon, Inc. | Gene-targeted mice with humanized Aβ sequence and Swedish FAD mutation |
| US5986054A (en) | 1995-04-28 | 1999-11-16 | The Hospital For Sick Children, Hsc Research And Development Limited Partnership | Genetic sequences and proteins related to alzheimer's disease |
| US6717031B2 (en) | 1995-06-07 | 2004-04-06 | Kate Dora Games | Method for selecting a transgenic mouse model of alzheimer's disease |
| PT920495E (pt) | 1996-07-24 | 2008-08-18 | Novartis Pharma Gmbh | Modelo animal transgénico para doença de alzheimer |
| US5898094A (en) | 1996-10-21 | 1999-04-27 | University Of South Florida | Transgenic mice expressing APPK670N,M671L and a mutant presenilin transgenes |
| US20030131364A1 (en) | 1999-04-27 | 2003-07-10 | Karen Duff | Method for producing transgenic animal models with modulated phenotype and animals produced therefrom |
| AU2001268005A1 (en) | 2000-07-07 | 2002-01-21 | Lars Lannfelt | Prevention and treatment of alzheimer's disease |
| US7196163B2 (en) * | 2001-05-22 | 2007-03-27 | Merk & Co., Inc. | Assays using amyloid precursor proteins with modified β-secretase cleavage sites to monitor β-secretase activity |
| US20040248766A1 (en) * | 2001-06-18 | 2004-12-09 | Andrea Leblanc | Selective inhibition of intracellular amyloid-beta neurotoxicity in human neurons |
| CA2504870A1 (en) * | 2002-11-04 | 2004-05-21 | Bioarctic Neuroscience Ab | Methods for the identification of agents that modulate the structure and processing of beta-amyloid precursor protein |
| US20040255341A1 (en) * | 2003-10-21 | 2004-12-16 | Envivo Pharmaceuticals, Inc. | Transgenic flies expressing Abeta42-Arctic |
-
2004
- 2004-03-22 SE SE0400707A patent/SE0400707D0/xx unknown
-
2005
- 2005-03-17 EP EP05722229A patent/EP1729569B1/de not_active Expired - Lifetime
- 2005-03-17 AT AT05722229T patent/ATE511348T1/de active
- 2005-03-17 CA CA002560551A patent/CA2560551A1/en not_active Abandoned
- 2005-03-17 DK DK05722229.1T patent/DK1729569T3/da active
- 2005-03-17 WO PCT/SE2005/000383 patent/WO2005089539A1/en not_active Ceased
- 2005-03-17 AU AU2005224992A patent/AU2005224992B2/en not_active Ceased
- 2005-03-17 JP JP2007504909A patent/JP4914343B2/ja not_active Expired - Fee Related
- 2005-03-17 US US10/593,639 patent/US7709695B1/en not_active Expired - Fee Related
- 2005-03-17 ES ES05722229T patent/ES2367310T3/es not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| SE0400707D0 (sv) | 2004-03-22 |
| ES2367310T3 (es) | 2011-11-02 |
| EP1729569A1 (de) | 2006-12-13 |
| AU2005224992B2 (en) | 2010-05-06 |
| DK1729569T3 (da) | 2011-09-19 |
| WO2005089539A1 (en) | 2005-09-29 |
| AU2005224992A1 (en) | 2005-09-29 |
| EP1729569B1 (de) | 2011-06-01 |
| CA2560551A1 (en) | 2005-09-29 |
| JP2007530035A (ja) | 2007-11-01 |
| JP4914343B2 (ja) | 2012-04-11 |
| US7709695B1 (en) | 2010-05-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Wengenack et al. | Quantitative histological analysis of amyloid deposition in Alzheimer’s double transgenic mouse brain | |
| Spires et al. | Transgenic models of Alzheimer's disease: learning from animals | |
| Radde et al. | The value of incomplete mouse models of Alzheimer’s disease | |
| ATE511348T1 (de) | Transgenes modell für morbus alzheimer | |
| DK2121944T3 (da) | In vivo screeningsmodeller til behandling af Alzheimers sygdom og andre QPCT-relaterede lidelser | |
| AU8448301A (en) | Remedies for heart failure | |
| Veldman et al. | The N17 domain mitigates nuclear toxicity in a novel zebrafish Huntington’s disease model | |
| WO2007149293A3 (en) | Transgenic flies expressing tau and amyloid precursor fragment | |
| Epis et al. | Searching for new animal models of Alzheimer′ s disease | |
| Willuweit et al. | Early-onset and robust amyloid pathology in a new homozygous mouse model of Alzheimer's disease | |
| Garringer et al. | Increased tau phosphorylation and tau truncation, and decreased synaptophysin levels in mutant BRI2/tau transgenic mice | |
| ATE548453T1 (de) | Material und methoden, involviert in die protein- aggregation neurodegenerativer krankheiten | |
| BRPI0510123A (pt) | modelos transgênicos de doença de alzheimer e seu uso no tratamento de uma variedade de doenças neurodegenerativas | |
| WO2006052691A3 (en) | Pet and magnetic resonance for screening alzheimer's disease therapeutics | |
| Lee et al. | Progressive neuronal loss and behavioral impairments of transgenic C57BL/6 inbred mice expressing the carboxy terminus of amyloid precursor protein | |
| Orta-Salazar et al. | Morphological analysis of the hippocampal region associated with an innate behaviour task in the transgenic mouse model (3xTg-AD) for Alzheimer disease | |
| ATE541923T1 (de) | Transgener c. elegans als modellorganismus für untersuchungen zur alzheimer'schen krankheit | |
| JP2005512550A5 (de) | ||
| Zeng et al. | Faithful expression of living color reporter genes in transgenic medaka under two tissue‐specific zebrafish promoters | |
| EP1688036A4 (de) | Transgenes nichthumanes säugetier | |
| DE60118913D1 (de) | Transgenes tiermodell für neurodegenerative erkrankungen | |
| WO2003093442A3 (en) | Cell cultures from animal models of alzheimer's disease for screening and testing drug efficacy | |
| WO2005094571A1 (ja) | 遺伝子改変ヘテロ動物及び該動物を用いたエキソサイトシスの計測方法 | |
| DE60121324D1 (de) | Tiermodel für neurodegenerative erkrankungen | |
| IL174726A (en) | Non-human animals with transgenic nucleic acid encoded by a mutant perinylin 1 protein |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1729569 Country of ref document: EP |